Abstract

Opioids are widely used as analgesics for oral mucositis in allogeneic hematopoietic cell transplantation (allo-HCT). Their main adverse events are nausea, vomiting, constipation, psychological symptoms, and respiratory depression. In our institute, continuous intravenous morphine was generally used until 2007, followed by intravenous fentanyl as the first-line agent because of its potential fewer adverse events. We retrospectively analyzed 99 patients who underwent allo-HCT in the University of Tsukuba Hospital from 2004 to 2009. Out of 99 patients, 64 were treated with opioids (morphine, 32 and fentanyl, 32). The attending physicians were in charge of providing stable pain control. Median age, sex, stem cell source, preparative regimen, and GVHD prophylaxis were similar in the two groups. There were no significant differences in psychological symptoms, drowsiness, nausea, and vomiting in both groups. Defecation ratio (the days having a bowel movement/the days taking opioids) was 63% and 94% in the morphine and fentanyl group, respectively (P < 0.0001). The percentage of patients who needed to use purgative drugs was 25% and 6% in the morphine and fentanyl group, respectively (P = 0.04). It is suggested that fentanyl has less adverse effects on gastrointestinal movement and is safer than morphine when used for oral mucositis in allo-HCT.

Highlights

  • Pain management for oral mucositis is important in hematopoietic cell transplantation (HCT) to maintain patient’s condition and quality of life

  • There were no statistical differences in median age, sex, graft source, preparative regimen, and GVHD prophylaxis between the two groups, while a larger number of acute lymphoblastic leukemia (ALL) patients were included in the morphine group (P < 0.01)

  • To the best of our knowledge, there has been no previous report on the comparison of continuous intravenous morphine and fentanyl for stomatitis after HCT

Read more

Summary

Introduction

Pain management for oral mucositis is important in hematopoietic cell transplantation (HCT) to maintain patient’s condition and quality of life. Insufficient pain management leads to inadequate oral care and difficulty with food intake. It can cause dehydration, malnutrition, and serious infections [1], and has been linked to inferior overall survival after HCT [2]. Morphine and fentanyl are widely used for pain control in HCT. In this institute, intravenous morphine was used until 2007 in most cases as the first line opioid, which was gradually substituted by intravenous fentanyl because constipation caused by morphine was thought to be problematic

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call